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Diabetic nephropathy (DN) is the leading cause of
renal failure in the world. It is characterized by
albuminuria and abnormal glomerular function and
is considered a hyperglycemic ‘‘microvascular’’
complication of diabetes, implying a primary defect
in the endothelium. However, we have previously
shown that human podocytes have robust responses
to insulin. To determine whether insulin signaling in
podocytes affects glomerular function in vivo, we
generated mice with specific deletion of the insulin
receptor from their podocytes. These animals
develop significant albuminuria together with histo-
logical features that recapitulate DN, but in a normo-
glycemic environment. Examination of ‘‘normal’’
insulin-responsive podocytes in vivo and in vitro
demonstrates that insulin signals through the MAPK
and PI3K pathways via the insulin receptor and
directly remodels the actin cytoskeleton of this cell.
Collectively, this work reveals the critical importance
of podocyte insulin sensitivity for kidney function.
INTRODUCTION
In 2007 in the United States, 54% of patients requiring dialysis or
renal transplantation had diabetes mellitus and the annual
economic cost of caring for these patients was in excess of $12
billion (U.S. Renal Data System, USRDS 2007 Annual Data
Report, http://www.usrds.org). This is similar in other parts of
the world, and these numbers are predicted to increase greatly
in forthcoming years due to theglobal epidemic of type 2 diabetes
(Zimmet et al., 2001).
The natural history of diabetic nephropathy (DN) is dominated
by progressive albuminuria. Initially, small amounts of albuminCellescape into the urine (microalbuminuria), and this develops
into overt albuminuria as nephropathy progresses. Not only
does albuminuria predict renal disease, it is also an independent
cardiovascular risk factor (Perkovic et al., 2008). The presence of
albuminuria suggests that the glomerular filtration barrier (GFB)
is an early target in this disease. The GFB is composed of two
cell types, podocytes and glomerular endothelial cells (GEnC)
(Pavensta¨dt et al., 2003), which are located on either side of
the glomerular basement membrane (GBM). The podocyte is
particularly important in maintaining the integrity of the GFB in
humans, as illustrated by a growing number of podocyte-
specific mutations, all of which result in significant albumin loss
into the urine (Lavin et al., 2008; Brown et al., 2010). Albuminuria
in DN has previously been considered to be predominantly
a consequence of hyperglycemia directed against the microvas-
culature (Nishikawa et al., 2000). However, microalbuminuria
also occurs in the insulin-resistant metabolic syndrome (it is
now one of the diagnostic criteria as defined by theWorld Health
Organization). This often occurs with a normal blood glucose
level and supports a nonhyperglycemic pathway of GFB disrup-
tion. Furthermore, there is growing evidence that podocyte
dysfunction plays an important role in the pathogenesis of DN
(Wolf et al., 2005). We have previously shown that in respect to
glucose uptake, podocytes and not GEnC are uniquely insulin-
sensitive cells in the glomerulus of the kidney and are able to
absorb glucose via translocation of the glucose transporters
GLUT1 and GLUT4 (Coward et al., 2005), dependent on the
podocyte protein nephrin (Coward et al., 2007). We now show
that insulin sensitivity is crucial in maintaining the integrity of
the GFB and, when lost, recapitulates features of DN.RESULTS
Specific Loss of Podocyte Insulin Signaling
Recapitulates Features of Diabetic Nephropathy
We generated two podocyte-specific insulin receptor knockout
mice (podIRKO) models by crossing floxed insulin receptor (IR)Metabolism 12, 329–340, October 6, 2010 ª2010 Elsevier Inc. 329
Figure 1. In Vivo Podocyte-Specific IR
Knockdown in Transgenic Mice
(A) Glomeruli of Z/EG reporter mice immuno-
stained with an anti-GFP antibody. Specific exci-
sion is demonstrated in podocytes (arrowed).
(B) Glomeruli were extracted and purified using
Dynabeads. This is light microscopic analysis of
the extract, showing a pure glomerular population
and the beads.
(C) PCR of genomic DNA from different tissues in
podIRKO compared with (cw) IRfl/fl Cre-negative
mice. Only podIRKO glomeruli have a smaller
excised genomic DNA band present (arrowed)
(G, glomeruli; S, spleen; E, ear).
(D) Podocyte isolation of CFP-positive podocytes
from 3-week-old podIRKO and control mice
demonstrates that the IR mRNA is knocked down
by over 90% in podocytes of the podIRKO mice
compared with other glomerular cells (OGC) that
were CFP-negative. In control mice, the IR is
increased by 60% in the podocyte fraction.
(E) There is increased production (100%) of IGF1
receptor mRNA in podocyte fraction of podIRKO
mice compared with a 50% reduction in the con-
trol mice.
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both the nephrin and podocin promoters. As we were moving
facilities, this had the advantage that we could analyze mice in
both a conventional facility (Mount Sinai, Toronto, Ontario: podo-
cin Cre IRKO) and a specific-pathogen-free facility (Toronto
Center for Phenogenomics: nephrin Cre IRKO) to allow us to
control for environment. Initially, we crossed our Cre-expressing
mice with lacZ/EGFP (Z/EG) reporter mice and ascertained that
there were good levels of excision exclusively in podocytes
(Figure 1A). We confirmed that the IR was knocked down specif-
ically in the podocyte in 3-week-old mice by studying genomic
excision of IR DNA in a variety of tissues in podIRKO and control
mice and found that genomic DNAwas excised in a pure glomer-
ular extract (Figure 1B) only from podIRKO mice (Figure 1C). We
went on to prove the IR was specifically knocked down in podo-330 Cell Metabolism 12, 329–340, October 6, 2010 ª2010 Elsevier Inc.cytes in the glomeruli of podIRKOmice by
isolating a pure podocyte fraction and
performing real-time PCR analysis. This
revealed at least a 90% knockdown in IR
message in podIRKO podocytes. In
contrast, there was increased IRmessage
in the podocytes of control mice when
compared to the other cells of their
glomeruli (Figure 1D).
PodIRKO mice were born with normal
Mendelian frequency and initially ap-
peared entirely normal. At 8 weeks, both
podIRKO models were comparable in
size to their littermates (Figures 2A and
2B), were normoglycemic, and had
comparable serum insulin levels (Figures
2C and 2D). The kidney size of these
animals was indistinguishable from their
controls (Figure 2E).Detailed renal investigation at 3 weeks of age was normal
in podIRKO mice with no abnormality identifiable using either
light (data not shown) or electron microscopic analysis
(Figure 3G). They were not albuminuric. However, at approxi-
mately 5 weeks of age, both podIRKO models (nephrin and
podocin Cre) started to develop albuminuria. The only histolog-
ical change at this time was loss of structure of the podocyte
foot process detected using electron microscopy (Figure 3G).
At 8 weeks of age, significant levels of albuminuria (Figures
2F and 2G) and histological changes were present in podIRKO
animals. These histological changes included extensive loss of
foot process structure of the podocyte (Figure 3G). Further-
more, there was evidence of podocyte apoptosis, as shown
by hyperchromatic condensed nuclei visualized by hematoxylin
and eosin (H&E) stain at 8 weeks of age (Figure 3A) and by
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Insulin and the PodocyteTUNEL staining at 13 weeks of age (Figure 3D). Furthermore,
podIRKO mice had increased amounts of glomerular matrix
(Figure 3B), which included type IV collagen (Figure 3C), thick-
ened GBM (Figures 3H and 3I) and increased levels of glomer-
ulosclerosis (Figure 3B). These are classical histological
features of DN (Wolf and Ziyadeh, 1999). As they aged, these
pathological features became more prominent (Figure 3E),
with some of the podIRKO mice developing macroscopically
shrunken and sclerosed kidneys (Figure 3F). However, we did
not find that mesangial hypercellularity was present on objec-
tive assessment (Figure 3B).
We detected phenotypic variation between individual po-
dIRKO mice both within the podocin and nephrin Cre groups
and between these groups (Figures 2G and 3B). The podocin
Cre animals were more albuminuric and had greater histological
abnormality and worse renal function (Figure 3B) in comparison
to the nephrin Cre mice. However, although there was variation,
both groups as a whole were significantly different from their
littermate controls. There are a number of possible explanations
for the variability between and within groups; first, the mice were
generated on mixed genetic backgrounds, so genetic modifiers
could be important. This could also explain the variability within
each group. It is recognized that genetic background is impor-
tant for severity of disease both in diabetic (Kulkarni et al.,
2003) and albuminuric models of renal disease (Gurley et al.,
2006). Second, the mice were housed in different facilities, and
it is likely that the podocin Cre mice, which were cared for in
a conventional facility, were exposed to more environmental
stressors, which may have resulted in a more severe phenotype.
Third, there may be differences in the efficiency of the Cre re-
combinase between the two lines, resulting in less IR excision
in the nephrin Cre mice.
We were interested to assess if compensation of IR loss was
occurring by upregulation of the IGF1 receptor, as insulin is
able to signal through both of these receptors (although signals
considerably less through the IGF1 receptor [Kurtzhals et al.,
2000]). In vivo, we found that IGF1 receptor mRNA was upregu-
lated in the podocytes of podIRKO mice (Figure 1E) compared
with controls. This suggests there is a cellular attempt to
compensate for IR loss, presumably to allow insulin to continue
to signal to the podocyte.
Insulin Signals to the Podocyte in the Glomerulus
To study insulin stimulated signaling in the glomerulus, we
utilized a mousemodel in which wild-type (WT) mice were fasted
overnight, thereby lowering insulin to basal levels, and then given
either insulin or saline via an intraperitoneal route. After 15 min,
they were sacrificed, and their kidneys were immediately snap-
frozen in liquid nitrogen in an attempt to preserve insulin-induced
protein phosphorylation. We elected to study the mitogen-acti-
vated protein kinase (MAPK), phosphatidylinositol 3-kinase
(PI3K), and cap/cbl pathways, as these are the signaling
cascades described in other rapidly insulin-sensitive cells
(adipocytes and muscle) (Chiang et al., 2001; Shepherd and
Kahn, 1999). Ex vivo, in the glomerulus, we could robustly iden-
tify insulin-stimulated signaling. For MAPK, the signaling was
exclusively detected in the podocyte using phosphospecific(p)
42 and 44 MAPK (Figures 4A and 4B). We assessed the PI3K
pathway by using pAKT (Ser473) and found again that signalingCellwas predominantly in the podocyte (Figure 4E). We confirmed
these observations by studying immortalized human podocytes
and GEnC in isolation and found that when the cells were
exposed to low doses of insulin (1 nM), insulin signaled to podo-
cytes via both theMAPK and PI3K pathways (Figures 4C, 4D, 4F,
and 4G), and that there was a small amount of PI3K signaling to
GEnC (Figure 4F) but not MAPK (Figure 4C). Finally, we ascer-
tained that podocyte insulin signaling was through the IR and
not through the IGF1 receptor by repeating the experiments
in vivo using podIRKOmice and in vitro using short hairpin siRNA
IR knockdown human podocytes (Figures 4B, 4C, 4E, and 4F).
These both showed abrogation of bothMAPK and PI3K signaling
pathways in response to insulin. We could not detect any effect
of insulin on the cap/cbl pathway in podocytes or GEnC (data not
shown).
Insulin Directly and Specifically Reorganizes the Actin
Cytoskeleton of Podocytes
Podocyte function in maintaining the integrity of the GFB is
dependent on its structure, particularly in the filamentous actin
(F-actin)-rich foot processes of this cell (Pavensta¨dt et al.,
2003). We therefore assessed if there was any role for insulin in
podocyte actin remodeling.
In vitro, we found that insulin directly remodeled the actin cyto-
skeleton of human podocytes, but not GEnC, in a dose-depen-
dent manner, causing cortical reorganization of F-actin, and
that this was IR dependent (Figures 5A–5C). Actin reorganization
resulted in changes in podocyte structure, particularly retraction
of cellular processes (akin to foot processes), as shown by high-
resolution atomic force microscopy (Figure 5D). Insulin also
increased podocyte cell motility and migration, as measured by
scratch assays (Figure 5E), and reduced its monolayer resis-
tance, as assessedby sensitive electrical cell impedance sensing
(ECIS) methodology (Figure 5F). This is a method that can accu-
rately detect changes in monolayer permeability and is particu-
larly good for studying cells that do not form tight monolayers in
culture, as is the case for podocytes in their differentiated form,
which is how they exist in vivo (Pavensta¨dt et al., 2003), and
when they are most insulin sensitive (Coward et al., 2005). As
with F-actin reorganization, insulin did not alter the monolayer
permeability in GEnC treated in the same manner (Figure 5F).
IGF1 has the ability to signal via the IR (Kurtzhals et al., 2000)
and shows considerable structural homology with insulin
(Rinderknecht and Humbel, 1978). However, we found function-
ally that IGF1 had no biological effect on actin remodeling, alter-
ation in monolayer electrical resistance (Figure S1), or migration
and motility (Figure 5E) of podocytes within the same time frame
as that observed for insulin.
We went on to explore the mechanism of insulin’s action on
podocyte actin remodeling by studying its effect on small
GTPases. Using our in vitro human model, we found that insulin
activated the GTP form of RhoA within 5 min and switched off
the GTP form of cell division cycle 42 (CDC42) within 2 min
(Figure 5G). This was confirmed using dominant-negative
constructs that were virally transfected into the cells. C3 trans-
ferase (dominant-negative Rho) prevented insulin-stimulated
cortical actin reorganization, and dominant-negative CDC42
(N17CDC42) resulted in cortical F-actin patterning in basal cells
(Figure 5H).Metabolism 12, 329–340, October 6, 2010 ª2010 Elsevier Inc. 331
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This study shows that insulin rapidly and directly signals to the
podocyte in the glomerulus, is able to dynamically remodel the
actin cytoskeleton of this cell, and has a critically important
role in maintaining the integrity of the GFB. Furthermore, when
podocyte insulin signaling is lost, glomerular changes develop
that recapitulate a number of features typical of DN.
The central hypothesis underpinning this study was that podo-
cyte-specific insulin sensitivity was important for glomerular
function. This had originated from our previous work on condi-
tionally immortalized human podocytes and GEnC suggesting
a specific response of differentiated podocytes to insulin in
respect to rapid glucose uptake. To explore this hypothesis,
we generated transgenic podIRKO mice. These mice were
born with normal Mendelian frequency, were indistinguishable
from littermates, and had no evidence of renal disease, implying
that insulin signaling to the podocyte is not critical for glomerular
development. This is similar to the whole-body IR knockout
mouse that is normal at birth but dies of diabetic ketoacidosis
at 72 hr (Accili et al., 1996), as well as an array of other tissue-
specific IRKO models that are also initially normal but develop
phenotypes as they age (Biddinger andKahn, 2006). Froma renal
perspective, we found no abnormality until 5 weeks of age, when
albuminuria started to appear, and the only histological abnor-
mality detectable was alterations in the structure of the
F-actin-rich podocyte foot processes. This is in keeping with
the observation that early in human DN, the cytoskeletal archi-
tecture of the podocyte is altered, as shown by foot process
widening (Bjørn et al., 1995; Pagtalunan et al., 1997). By 8 weeks
of age, podIRKO mice had developed significant albuminuria
together with histological changes typical of DN (Alsaad and
Herzenberg, 2007). These included loss of podocyte
morphology, production of large amounts of matrix (including
type IV collagen), increased GBM thickness, and glomeruloscle-
rosis. There was also evidence of podocyte apoptosis. This is
important, as podocyte loss is a feature of DN that occurs rela-
tively early in its natural history and is an excellent predictor of
disease progression that is superior to other pathological
features, including mesangial expansion, matrix accumulation,
and thickening of the GBM (Pagtalunan et al., 1997; Wolf et al.,
2005). Interestingly, the kidneys of the podIRKO mice were not
enlarged, and on objective analysis of the glomerular mesan-
gium, we found no evidence of hypercellularity. These are also
characteristic features of human DN and imply that there may
be aspects of DN that are the result of podocyte insulin resis-
tance (podocyte actin disorganization and loss of foot process
structure, increased matrix, thickening of GBM, podocyteFigure 2. PodIRKO Mice Are Normoglycemic and Normally Grown at 8
(A) Macroscopically, mice were indistinguishable.
(B) No difference between podIRKO and littermate controls after formal weighing
(C) They had comparable random blood glucose levels in both podocin and nep
(D) No difference in serum insulin levels in a subset of mice at 8 weeks.
(E) Macroscopically no difference in kidney size between podIRKO and control m
(F) At 8 weeks, podIRKO mice become albuminuric. SDS-PAGE gel shows spec
loaded for each).
(G) Significant proteinuria in podIRKO mice generated on different Cre promoter
strains and within the groups (***p < 0.001, nR 10 each group, mean ±SEM sho
Cellapoptosis, and glomerulosclerosis) and aspects that are not
(kidney enlargement and mesangial expansion). It may be that
the insulin-nonresistant podocyte features are consequences
of hyperglycemic or insulin-resistant effects on the other cells
of the kidney (GEnC and mesangium).
Our results suggest that insulin resistance of the podocyte
may be an important initiator for many of the pathological
processes observed in DN. In respect to glucose uptake and
actin remodeling, we have found that GEnCs do not rapidly
respond to insulin. However, there is evidence that insulin also
directly signals to the vascular endothelium (Potenza et al.,
2009), controlling features such as vascular tone via nitric oxide.
Currently, there are nomurinemodels that are able to specifically
target the GEnC. If they become available, they will be helpful in
defining the direct role of insulin signaling on GEnC and whether
this is also important for glomerular function.
Cellular insulin resistance is central to the development of the
metabolic syndrome and type 2 diabetes. A role for podocyte
insulin resistance in the progression of nephropathy in these
situations is therefore conceptually easy to understand. En-
hancement of podocyte insulin sensitivity may also explain
how thiazolidinediones delay or stop progression of nephropathy
in these settings (Panchapakesan et al., 2005). Type 1 diabetes is
caused by insulin deficiency, but the associated nephropathy is
similar to type 2 diabetes in respect to both its natural history and
histological features. Conceptually, in type 1 DN, podocyte
insulin resistance would appear not to be important. However,
there is compelling evidence that patients with type 1 diabetes
who develop nephropathy are also more insulin resistant at
a cellular level compared to those patients who do not develop
kidney disease. Type 1 nephropathic patients often require
higher doses of insulin to treat their diabetes (Andersen et al.,
1983), have higher levels of cellular insulin resistance as deter-
mined by objective euglycemic clamp studies (Orchard et al.,
2002), and are more likely to have a positive family history of
cellular insulin resistance (Hadjadj et al., 2004). Furthermore,
type 1 diabetes itself induces cellular insulin resistance when
prolonged (Yki-Ja¨rvinen and Koivisto, 1986), and nephropathy
commonly takes years to develop. Therefore, it is distinctly
possible that podocyte insulin resistance is also influential in
the development of nephropathy in type 1 diabetes. Therapeuti-
cally, this is important, as it implies that cellular insulin sensitizers
could be beneficial in preventing or slowing progression of
nephropathy in this setting. This is supported by a number of
type 1 diabetic animal models (Isshiki et al., 2000; Nicholas
et al., 2001; Zhang et al., 2008) in which insulin sensitizers
have been shown to slow renal disease progression independent
of glycemic control.Weeks of Age but Have Albuminuria
(mean ±SEM, nR 10 each group).
hrin Cre groups (mean ±SEM, nR 10 each group).
ice at 8 weeks.
ific band at 66 kDa corresponding to albumin only in podIRKO mice (2 ml urine
s, raised in different environments. However, there is variability both between
wn).
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Insulin and the PodocyteIt was not surprising that insulin signals to the podocyte
through both the MAPK and PI3K pathways, given the ex-
tensive literature on other rapidly insulin-responsive cells,
such as adipocytes and skeletal muscle (Shepherd and Kahn,
1999), and work performed on podocytes by us (Coward et al.,
2005) and other groups (Tejada et al., 2008). However, the impor-
tance and specificity of this effect in the kidney has not been
previously reported. We found that the rapid effects of insulin
in phosphorylating key molecules in these pathways (p42/p44
MAPK and pAKT [Ser473]) occurred predominantly in the podo-
cyte of the kidney. We went on to knock down the IR both in vivo
and in vitro, revealing that in both models, these signaling path-
ways were abrogated. This supports the notion that insulin
signals predominantly through the IR in podocytes and not
through the IGF1 or hybrid IGF1/IR receptor.
Insulin directly, rapidly, and specifically reorganized the actin
cytoskeleton of normal human podocytes, again via the IR, and
loss of podocyte foot process cytoskeletal architecture was the
earliest abnormality detected in theGFBof our podIRKOmodels.
This raises the possibility that insulin is normally able to maintain
the structure of the foot process of the podocyte and hence
prevent breakdown of the GFB. We speculate that in healthy
conditions, insulin-induced dynamic remodeling of the podocyte
and particularly its foot process occurs physiologically after
a meal to deal with the increased filtration load the GFB experi-
encesat this time.Webelieve this is facilitatedby the insulin-stim-
ulated uptake of glucose into this cell through translocation of
glucose transporters (Coward et al., 2005) as a source of energy.
Podocyte actin reorganization was achieved through activa-
tion of RhoA and inhibition of CDC42. This is consistent with
studies that have examined the activation state of these small
GTPases in models of relaxation (Zhang et al., 2007) and tight-
ening (Gao et al., 2007) of cell junctions between podocytes.
Ourwork has shown that insulin-activated RhoA causes contrac-
tion and cortical reorganization of F-actin. This is not the case for
fibroblasts that have been most intensely studied (Nobes and
Hall, 1995), where RhoA induces stress fibers. However, corticalFigure 3. PodIRKO Mice Develop Histological Features of Diabetic Ne
(A) Light microscopy for podocin Cre podIRKO mice and controls aged 8 weeks
power PAS; and lower, H&E staining at high power. PodIRKO (middle column
show increased mesangial matrix production. Several glomeruli appear shrunken
segments show adhesion to Bowman’s capsule, segmental scarring, and capillar
matic, condensed nuclei suggestive of apoptotic bodies (arrowed bottom middle
large protein absorption droplets.
(B) Objective histological glomerular scoring reveals significant levels of glomeru
Histological abnormality is more marked in the podocin animals. No difference in
nR 10 each group, mean ±SEM shown). Plasma creatinine levels were measured
mice, but in the podocin Cre IRKO animals, there was a mildly raised creatinine
(C) Type IV collagen progressively accumulates in glomeruli of podIRKO mice (b
(D) Podocyte apoptosis is detected using TUNEL stain in 13-week-old podIRKO
(E) Light microscopy of 13-week-old podIRKO (nephrin promoter) showed ma
mesangial expansion, and protein in the tubules in comparison to the 8-week-oldm
PAS staining.
(F) Some 13-week-old podIRKO mice had small sclerosed kidneys.
(G) Transmission electron microscopy of podIRKO and control mice. PodIRKO m
cytoskeleton is beginning to become deranged, with broadening of foot proce
No obvious changes were detected in the GEnC.
(H) Thickening of the GBM of podIRKO mice when measuring the lamina densa.
(I) Multiple sections from three mutant mice were compared with three control mic
formed perpendicular with the edge of the GBM. **p = 0.007, mean ±SEM show
Cellreorganization has been shown to occur in other cell types (Mad-
dox and Burridge, 2003), and RhoA-induced loss of processes is
a commonfinding in neurons (Postmaet al., 1996), a cell typewith
a number of similarities to podocytes (Kobayashi et al., 2004).
Collectively, this work shows that the podocyte is a uniquely
insulin-sensitive cell in the kidney and is able to rapidly remodel
its actin cytoskeleton and morphology in response to insulin.
Furthermore, insulin signaling to this cell is critically important
for the glomerulus to function normally and, when diminished,
results in a number of pathological features that are similar to
DN. Enhancing insulin sensitivity of the podocyte is an attractive
approach in the treatment of the commonest cause of renal
failure in the world.EXPERIMENTAL PROCEDURES
In Vivo Studies
Transgenic Mice Studies
PodIRKO mice were generated by crossing transgenic mice who had loxP
sites inserted on either side of exon 4 (Bru¨ning et al., 1998) of their IR with
transgenic Cre recombinase-producing mice that targeted the podocyte by
virtue of their podocyte-specific podocin (Ding et al., 2006) and nephrin (Ere-
mina et al., 2003) promoters. PodIRKO mice were homozygous for the floxed
IR gene and heterozygous for Cre recombinase. These animals were on
a mixed genetic background, with contributions from C57BL/6, 129/SV, and
FVB strains. Mice were genotyped using PCR as previously described (Bru¨n-
ing et al., 1998; Ding et al., 2006; Eremina et al., 2003). Control mice were litter-
mates of podIRKOs and included flox/flox IR mice without Cre together with
Cre-positive mice with no floxed IR present. They were all fed on standard
chow. Z/EG reporter mice (Novak et al., 2000) were initially crossed with the
Cre-producing mice as previously described to ensure specific excision in po-
docytes. All animal husbandry was carried out in accordance with the Cana-
dian Council on Animal Care protocols, and protocols were approved by the
animal care committee at the Samuel Lunenfeld Research Institute.
CFP Podocyte Isolation and Quantitative Real-Time PCR
To isolate podocytes from glomeruli, we utilized the nephrin cyan fluorescent
protein (CFP) mouse (Cui et al., 2005), which has CFP linked to the nephrin
promoter and is able to label podocytes. These mice were crossed with po-
dIRKO mice, and animals were generated that were heterozygous for nephrin
CFP and podocin Cre and homozygous for loxP IR. These were thenphropathy
. Top panels are low-power Periodic Acid Schiff (PAS) staining; middle, high-
) demonstrate dilated tubules containing proteinaceous casts. The glomeruli
, associated with foci of segmental glomerulosclerosis. The affected glomerular
y insudative (hyalinotic) lesions. Occasional podocytes show small, hyperchro-
panel). Focal glomeruli show podocyte and parietal epithelial cell swelling with
losclerosis and matrix accumulation in both the podocin and nephrin cre mice.
mesangial hypercellularity was detected (*p < 0.05, **p < 0.005, ***p < 0.0005,
in a subset of mice at 8 weeks. No difference was detected in the nephrin Cre
level in mutants when compared to controls.
rown staining).
mice (nephrin promoter) (apoptotic nuclei arrowed).
ssive amounts of matrix formation as well as increased glomerulosclerosis,
ice. Right, high power (363magnification); left, low power (310magnification)
ice have normal GFB at 3 weeks of age. By age 5 weeks, the podocyte actin
sses (arrowed). Foot processes are completely lost by 8 weeks (arrowed).
e. Each section had at least ten measurements of lamina densa thickness per-
n.
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Figure 4. Insulin Signals to the Podocyte in the Glomerulus
(A) MAPK signaling. Mice given insulin phosphorylated p42/44 MAPK only in the glomerulus (310 magnification). Green, p42/44MAPK; red, PECAM (endothelial
marker); blue, nephrin (podocyte marker).
(B) Using high-power confocal microscopy (363 magnification), insulin-stimulated p42/44 MAPK colocalizes with nephrin, demonstrating specific podocyte
signaling (middle row, representative of three independent experiments). PodIRKO mice were unable to phosphorylate p42/44 MAPK in response to insulin
stimulation (lower row).
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Insulin and the Podocytecompared to other control nephrin CFP-positive mice that were also hetero-
zygous for only podocin Cre or homozygous for the floxed IR gene. Animals
were sacrificed and their kidneys passed through a 105 mm sieve and caught
on a 71 mm sieve. A single-cell suspension was made by incubating the
glomeruli in digestion buffer containing 0.2% trypsin, 1 mg/ml collagenase
A, 2 mg/ml EDTA, and 100 U/ml DNase I at 37C for 40 min. 7-aminoactino-
myocin was added to the cells just prior to FACS sorting to identify dead
cells, which were excluded in the sort. They were then FACS sorted, and
gating was set to isolate a pure CFP-positive population. These were
compared to CFP-negative cells from the glomerular sort. To ensure we
had isolated a pure podocyte population in the CFP-positive fraction, we
measured mRNA production of nephrin (podocyte marker) and platelet/endo-
thelial cell adhesion molecule 1 (PECAM) (endothelial marker) in both frac-
tions. We found substantially more nephrin and less PECAM in the CFP-posi-
tive fraction, indicating we had specifically isolated podocytes in our
experiments (Figure S2).
To obtain enough mRNA from these experiments, we needed to pool
three mice from both the CFP-positive podIRKO group and from the control
group. Messenger RNA was prepared using TRIzol and reverse transcribed
into cDNA using the reverse first-strand DNA synthesis kit (Fermentas; Bur-
lington, Ontario, Canada). Expression for the IR, IGF1 receptor, nephrin, PE-
CAM, and HPRT (housekeeping gene) was measured. The primers used are
shown in Table S1. The comparative DDCT method of relative quantification
was used to calculate for differences in gene expression using the software
for ABI Prism 7900 Sequence Detection system (Applied Biosystems; Carls-
bad, CA).
Glomerular Isolation and Detection of Genomic Excision of the IR
This was performed as previously described (Cui et al., 2005) with the use of
magnetic Dynabeads. Identification of IR gene excision was achieved by
RT-PCR with primers flanking the loxP sites situated in the IR gene. The primer
sequence used was forward, TCTATCATGTGATCAATGATTC and reverse,
ATACCAGAGCATAGGAG.
Glomerular Insulin Signaling in WT Mice
We used the same approach as previously described (Patel et al., 2008) to
prepare, dose with insulin, and isolate the kidneys of thesemice. Phosphospe-
cific antibodies against 42/44 MAPK and Ser473 AKT were purchased from
Cell Signaling (Danvers, MA).
Histological Analysis
Kidneys were processed as previously described (Eremina et al., 2003). We
used phospho-antibodies from Cell Signaling to detect insulin-stimulated
phosphorylated proteins in both the tissue immunofluorescence and in our
cell culture experiments. Nephrin (Acris; Herford, Germany), PECAM (Pharmin-
gen; San Diego, CA), and type IV collagen (Cedarlane; Burlington, NC) anti-
bodies were used in the mouse experiments. Immunohistochemistry was
performed on formalin-fixed tissue as previously described (Eremina et al.,
2003), as was the TUNEL stain (Wijsman et al., 1993). Electron microscopy
was achieved using a technique similar to one previously employed (Eremina
et al., 2003), with one variation. The fixation buffer consisted of 0.1 M sodium
cocodylate and 2% glutaraldehyde. Blinded analysis of glomerular histology
was performed by an experienced histopathologist (A.M.H.) (Supplemental
Experimental Procedures).
In Vitro Studies
Immortalized Cells
Conditionally immortalized human podocytes and GEnC were used as previ-
ously described (Saleem et al., 2002; Satchell et al., 2006). Podocytes were
studied 2 weeks after thermoswitching from 33C to 37C. Thermoswitching
silences a temperature-sensitive SV40 gene in the cells, which prevents
them from entering the cell cycle (as occurs at 33C) and allows them to differ-(C) p42/44 MAPK is switched on at 15 min with both low-dose (1 nM) and high-do
down podocyte cell lines and GEnC in response to low-dose insulin.
(D) Densitometry in WT podocytes reveals a 120% increase in insulin-stimulated
(E) pAKT signaling is predominantly in podocytes after 15 min stimulation with in
independent experiments). Insulin-stimulated AKT phosphorylation was abrogat
(F) AKT is phosphorylated inWT human podocytes by 15min at both low- and high
contrast to MAPK, there is a small amount of pAKT detectable in human GEnC i
(G) Densitometry shows a 200% increase in pAKT phosphorylation in response
Cellentiate. This is important, as in vivo podocytes are terminally differentiated
cells. Conditionally immortalized podocytes express cellular markers and
morphologically resemble differentiated podocytes. Two different WT podo-
cyte cell lines and one endothelial cell line were studied. Different clones of
each cell line were studied to ensure we were not observing a clonal effect.
Passage numbers between 10 and 15 were examined.
Insulin Stimulation
Cells were insulin and fetal calf serum (FCS) starved for at least 12 hr prior to
stimulation. They were treated with insulin doses ranging from 0.1 mM to
200 mM for 15 min to assess actin reorganization. To elucidate signaling path-
ways, a dose of 100 nM for 15 min was used, which is common practice in
insulin cell signaling studies.
Immunofluorescence
Cells were prepared in 96-well CellBIND plates (Nunc; Roskilde, Denmark) or
on glass coverslips (Menzel-Gla¨ser; Braunschweig, Germany). Theywere fixed
in 4% paraformaldehyde for 15 min, permeabilized with 0.2% Triton, and then
washed with 0.1% sodium borohydride. The actin cytoskeleton was visualized
using phalloidin-conjugated Alexa Flour 488 or Texas Red (Invitrogen) and
nuclei using DAPI (Sigma). Cells were imaged using the IN Cell Analyzer
(GE Healthcare), and changes were assessed and processed using the multi-
target analysis algorithm software as recently described (Caunt et al., 2008).
The IN Cell Analyzer is able to detect cells by virtue of their nuclei (DAPI stain-
ing); it then objectively identifies actin patterning and assigns each cell as
having either cortical or cytoplasmic distribution.
Atomic Force Microscopy
Atomic force microscopy was carried out on a commercial instrument (Nano-
Scope IIIa Controller and Dimension head; Veeco; Cambridge, UK) using stan-
dard triangular silicon nitride cantilevers with a nominal spring constant of
0.32 N/m (Olympus ORC8; Veeco). Cells were fixed with 4% sucrose/2%
paraformaldehyde and then imaged using intermittent contact mode in liquid
(under phosphate-buffered saline) (Tamayo et al., 2001).
Activated GTPase Assays and Dominant-Negative Studies
Measurement of the GTP form of CDC42 was achieved using EZ-Detect Small
GTPase Kits (Pierce; Northumberland, UK). Activated GTP RhoA was per-
formed using the same techniques as recently reported (Lennon et al.,
2008). Rho and CDC42 dominant-negative adenoviral constructs were gener-
ated byMyc-tagged C3-transferase and N17CDC42mutants being subcloned
them into pacAd vectors. These were fully sequenced and transfected into
differentiated podocytes 24 hr prior to experimentation. We found that adeno-
viral transfection was excellent (greater than 95%) in podocytes using adeno-
viral GFP-tagged RhoA and CDC42 constructs (Figure S3).
Electrical Cell Substrate Impedance Sensing
Time course analysis and resistance measurement was performed using an
automated cell monitoring system, Electrical Cell-Substrate Impedance
Sensing (ECIS 1600R, Applied Biophysics; Rochester, NY), as recently
described (Satchell et al., 2007). This detects nanometer scale changes in
cell morphology in real time by virtue of the changes in electrical resistance
it detects. Briefly, immortalized podocytes and endothelial cells were seeded
onto gold microelectrodes in wells of ECIS arrays (eight wells, ten electrodes
per well). Confluent cell monolayers were treated with 100 nM insulin or vehicle
control in usual medium. Using the ECIS attachment mode resistance was
measured at regular time intervals of 30 s. The ratio of measured resistance
to baseline resistance was calculated for each well and plotted as a function
of time, normalized to control.
Scratch Assay
This was performed as previously described (Vollenbro¨ker et al., 2009).
Short Hairpin Insulin Receptor Knockdown
Specific lentiviral transduction particles (Sigma) were used to produce stable
knockdown human podocyte cell clones. The lentiviral transduction particlesse (100 nM) insulin in WT human podocytes. This does not occur in IR knock-
p42/44MAPK at 15 min (p = 0.0093, n = 6, mean ±SEM shown).
sulin in WT mice (upper and middle panels, representative images from three
ed in podIRKO mice (lower panels).
-dose insulin. This does not occur in insulin receptor knockdown podocytes. In
n response to low- and high-dose insulin.
to insulin in human podocytes (**p = 0.007, n = 6, mean ±SEM shown).
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the gene sequence. Therefore, a range of knockdown efficiency can be
expected. Proliferating podocytes at 33C were coincubated with approxi-
mately 525 lentiviral transducing particles in standard culturemedia containing
Polybrene (Sigma) for 24 hr. Following viral incubation, the cells were washed
with normal media, then left to recover for a further 24 hr in fresh media before
the addition of puromycin dihydrochloride. Antibiotic selection pressure was
exerted on the cells until individual puromycin-resistant colonies of cells devel-
oped. These clones were then selected, expanded, and examined for their
level of receptor knockdown. We analyzed knockdown by western blot and
quantitative real-time PCR and studied a clone that had 70% knockdown of
the IR (Figure S4).
Statistics
Comparison between two groups was performed using Student’s t test. For
more than two groups, analysis of variance with a post hoc Bonferroni was
used. Statistical significance was defined as a p value less than 0.05. Standard
error of the mean (SEM) is shown for each population.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental References, four figures, and one table and can be found with
this article online at doi:10.1016/j.cmet.2010.08.015.
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